drugset / Trial / NCT01963455

Autologous Muscle Derived Stem Cells Transplantation in Urine Incontinency

NCT01963455 ↗

Phase 1 Completed 10 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

This study was designed to provide confirmation of safety of muscle derived cell (MDCs) for the treatment of stress urine incontinency (SUI) in women.

Timeline

Start
2013-01
Primary completion
2014-08
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MDCs Cell therapy 3e+07 cells Other